ArticleBMC pulmonary medicine2021

Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report.

Flávia Amaral Duarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.